Erythropoietin stimulates the coronary collateral development in patients with coronary chronic total occlusion

Yuksel, I.; Cagirci, G.; Koklu, E.; Yilmaz, A.; Kucukseymen, S.; Ellidag, H.; Cay, S.; Yilmaz, N.; Arslan, S.

doi:10.1007/s12471-016-0875-x

Erythropoietin stimulates the coronary collateral development in patients with coronary chronic total occlusion

Copy For Citation

Yuksel I. O., Cagirci G., Koklu E., Yilmaz A., Kucukseymen S., Ellidag H. Y., ...More

NETHERLANDS HEART JOURNAL, vol.24, no.10, pp.609-616, 2016 (SCI-Expanded)

Publication Type: Article / Article
Volume: 24 Issue: 10
Publication Date: 2016
Doi Number: 10.1007/s12471-016-0875-x
Journal Name: NETHERLANDS HEART JOURNAL
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.609-616
Keywords: Chronic total occlusions, Coronary collateral development, Serum erythropoietin level, SMOOTH-MUSCLE-CELLS, ACUTE KIDNEY INJURY, SERUM ERYTHROPOIETIN, HEART-FAILURE, DNA-SYNTHESIS, INFARCT-SIZE, ACTIVATION, LEVEL, CIRCULATION, ANEMIA
Akdeniz University Affiliated: Yes

Abstract

Objective Erythropoietin (EPO) improves cardiac function and induces neovascularisation in post-myocardial infarction heart failure. The aim of this study was to analyse the association between the serum erythropoietin level and coronary collateral development in patients with coronary artery disease and chronic total occlusion.